NEW culturally adapted resources available now
Our Vision
Our Vision
Our vision is to reduce the devastating impact of stillbirth for women, families and the wider community through improving care to reduce the number of stillborn babies and to reduce the impact of this loss.
People + Partners
People + Partners
Meet the network of people, organisations, and professional institutions driving research and program implementation across the Stillbirth CRE.
Our work
Our Work
Explore some of the latest Stillbirth CRE research projects, scientific studies, and educational campaigns on stillbirth prevention and care after stillbirth.
Parent STories
News + Events
News + events
View the latest news and events from the Stillbirth CRE and our collaborating partners.
Get Involved
Get Involved
There's so many ways to contribute to stillbirth research. Sign up to our newsletter to stay in touch with the latest news, join our community, make a donation, or participate in research. Find out all the ways to Get Involved.
Safer Baby in pregnancy
Care after loss
Seeking Support
Research and news

Our aim is to improve care to reduce the number of stillborn babies and to reduce the impact of this loss.
Frequently asked questions
Get Involved
Get Involved

Developing a new blood test for FGR

Project Status In Progress
Funding Amount $5,000,000.00
Organisation Lead University of Melbourne
Lead Investigator Susan Walker
Program Area New Approaches To Prevention
Topic Improving Data Capture To Prevent Stillbirth In Australia
Contact Susan Walker at spwalker@unimelb.edu.au

To improve detection of fetal growth restriction (FGR)- the leading risk factor for stillbirth- our novel approach to biomarker discovery is to target proteins that are known to be *very highly expressed in placenta*. Proteins highly expressed in the placenta are more likely to have important biological roles, and thus more likely to have altered expression in placental insufficiency. These changes can then be detected with a simple maternal blood test. This approach has already proven successful: we have identified many circulating proteins that are differentially expressed in the blood of mothers carrying a baby destined to be born small. Of these, a little-known protein named SPINT1 may be the best blood marker for a small baby yet reported. We expect to discover more potential biomarkers over the next 5 years, and to bring them together in a multi-marker algorithm to improve detection of FGR. Improving detection of FGR enables closer surveillance and well-timed delivery to reduce stillbirth risk.

magnifiercross